𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Successful Induction of Tumor-specific Cytotoxic T Lymphocytes from Patients with Non-small Cell Lung Cancer Using CD80-transfected Autologous Tumor Cells

✍ Scribed by Takenoyama, Mitsuhiro ;Yoshino, Ichiro ;Eifuku, Ryozo ;So, Tomoko ;Imahayashi, Satoru ;Sugaya, Masakazu ;Yasuda, Manabu ;Inoue, Masaaki ;Ichiyoshi, Yuji ;Osaki, Toshihiro ;Nagashima, Akira ;Nomoto, Kikuo ;Yasumoto, Kosei

Book ID
108581998
Publisher
Wiley (Blackwell Publishing)
Year
2001
Tongue
English
Weight
88 KB
Volume
92
Category
Article
ISSN
0910-5050

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Induction of autologous tumor-specific c
Induction of autologous tumor-specific cytotoxic T cells in patients with liver cancer. Characterizations and clinical utilization
✍ Atsushi Aruga; Katsumi Yamauchi; Ken Takasaki; Takaji Furukawa; Fujio Hanyu πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 838 KB

Effectoritarget ratio.AJsually 5'Cr release assays were performed for 4 hr except in Exp. 6, which was for 18 hr.-The data are means \* standard deviation of triplicate determinations.

CD80 expression in an HLA-A2-positive hu
CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer
✍ Dale L. Bixby; John R. Yannelli πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 185 KB πŸ‘ 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix

Tumor-specific CD8+ T lymphocytes derive
Tumor-specific CD8+ T lymphocytes derived from the peripheral blood of prostate cancer patients by in vitro stimulation with autologous tumor cell lines
✍ Franck Housseau; Daniel A. Langer; Samuel D. Oberholtzer; Anitha Moorthy; Hyam I πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 150 KB πŸ‘ 2 views

## Abstract To identify tumor‐associated antigens as putative targets for developing immunotherapies against prostate cancer, we investigated the ability of T cells derived from the peripheral blood lymphocytes of prostate cancer patients to recognize autologous tumor cells. The technical challenge